Business Development Opportunities

Detection of Clostridium difficile in 40 minutes*

45-minute detection & differentiation of Clostridium difficile & the Epidemic 027 strain

Xpert^® Carba-R is a qualitative, on-demand real-time PCR test for the detection and differentiation of KPC, NDM, VIM, OXA-48 and IMP in 48-minutes

Accurate, Fast, On-demand PCR Test That Detects MRSA Directly from Nasal Swabs

Accurate detection of MRSA and SA in positive blood culture specimens in about an hour

Detect MRSA & SA Skin and Soft Tissue Infections In About One Hour

Accurate and Easy to Use with Fast Results When Time Matters

Pre-surgical testing of S. aureus and MRSA in about an hour

The first rapid & accurate test to assist with VRE surveillance

Fast Molecular In Vitro Diagnostic Enteroviral Meningitis Test

Accurate Detection of MTB and Rifampin Resistance Mutations

On-demand Mpox testing provides accurate point-of-care results in approximately 36 minutes

Designed with 3 gene targets for a rapid, robust detection of SARS-CoV-2.

Actionable, rapid respiratory results to meet the challenges of the ongoing pandemic.

Accurate and reliable detection of Flu A and Flu B in as soon as 20 minutes*

Accurate and reliable detection of Flu A, Flu B or RSV in as soon as 20 minutes*

Actionable rapid respiratory results to meet the challenges of the ongoing pandemic.

Actionable rapid respiratory results to meet the challenges of the ongoing pandemic.

Qualitative real-time PCR test providing accurate detection of Group A Streptococcus in as soon as 18 minutes.

Fast and Accurate Diagnosis of Trichomoniasis in 90 minutes or less

90-minute detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)

For direct intrapartum screening in labor/delivery

Xpert^® Xpress MVP is a new FDA cleared, on-demand PCR test to aid in the diagnosis of vaginal infections in symptomatic women within an hour.

For antepartum screening

On-demand GBS molecular testing for antepartum screening

Quantitative assay of the NPM1 mRNA transcripts (Type A, B, and D) and the ABL1 endogenous control mRNA transcript in EDTA peripheral blood samples. For Research Use Only (RUO). Not for use in diagnostic procedures.

Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with chronic myelogenous leukemia (CML)

Quantitative assay for the BCR-ABL minor breakpoint (p190) transcript. For Research Use Only (RUO). Not for use in diagnostic procedures.

30-Minute Test for Genetic Risk of Thrombosis